US20020087107A1 - Methods and devices for maintaining cardiopulmonary bypass and arresting a patient's heart - Google Patents
Methods and devices for maintaining cardiopulmonary bypass and arresting a patient's heart Download PDFInfo
- Publication number
- US20020087107A1 US20020087107A1 US09/401,734 US40173499A US2002087107A1 US 20020087107 A1 US20020087107 A1 US 20020087107A1 US 40173499 A US40173499 A US 40173499A US 2002087107 A1 US2002087107 A1 US 2002087107A1
- Authority
- US
- United States
- Prior art keywords
- patient
- lumen
- blood
- pump
- cannula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3666—Cardiac or cardiopulmonary bypass, e.g. heart-lung machines
- A61M1/3667—Cardiac or cardiopulmonary bypass, e.g. heart-lung machines with assisted venous return
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3613—Reperfusion, e.g. of the coronary vessels, e.g. retroperfusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M2025/0004—Catheters; Hollow probes having two or more concentrically arranged tubes for forming a concentric catheter system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
- A61M25/0023—Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
- A61M25/0026—Multi-lumen catheters with stationary elements
- A61M25/003—Multi-lumen catheters with stationary elements characterized by features relating to least one lumen located at the distal part of the catheter, e.g. filters, plugs or valves
- A61M2025/0031—Multi-lumen catheters with stationary elements characterized by features relating to least one lumen located at the distal part of the catheter, e.g. filters, plugs or valves characterized by lumina for withdrawing or delivering, i.e. used for extracorporeal circuit treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/04—Liquids
- A61M2202/0468—Liquids non-physiological
- A61M2202/047—Liquids non-physiological cardioplegic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/12—General characteristics of the apparatus with interchangeable cassettes forming partially or totally the fluid circuit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/12—Blood circulatory system
- A61M2210/125—Heart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
- A61M25/0023—Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
- A61M25/0026—Multi-lumen catheters with stationary elements
- A61M25/0032—Multi-lumen catheters with stationary elements characterized by at least one unconventionally shaped lumen, e.g. polygons, ellipsoids, wedges or shapes comprising concave and convex parts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0068—Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
- A61M25/007—Side holes, e.g. their profiles or arrangements; Provisions to keep side holes unblocked
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S128/00—Surgery
- Y10S128/03—Heart-lung
Definitions
- the present invention relates to systems for arresting a patient's heart and maintaining a patient on cardiopulmonary bypass. Such systems are used when performing surgical procedures, such as coronary artery bypass grafting, on an arrested heart.
- the systems described in U.S. Pat. Nos. 5,584,803 and 5,558,644 include an aortic occlusion device which has a balloon to occlude the ascending aorta and a lumen to deliver cardioplegic fluid for arresting the patient's heart.
- the aortic occlusion device replaces the conventional external cross-clamp and advantageously reduces the amount of displacement and distortion of the aorta. Minimizing distortion of the aorta may reduce the amount of emboli released and, therefore, may reduce stroke incidents.
- a venous cannula withdraws blood from the patient and blood is returned to the patient through an arterial cannula which is placed at a peripheral artery such as the femoral artery.
- the aortic occlusion device passes through the arterial cannula thereby minimizing the number of penetrations in the patients vascular system.
- the systems described in U.S. Pat. Nos. 5,584,803 and 5,558,644 also include an endovascular coronary sinus catheter for retrograde perfusion of a cardioplegic agent, preferably blood cardioplegia, via the coronary sinus.
- the coronary sinus catheter preferably passes through the internal jugular vein and has an inflatable balloon for occluding the coronary sinus.
- An endovascular venting catheter extends through the tricuspid and pulmonary valves for venting the pulmonary artery.
- the extracorporeal bypass circuit which couples the catheters and cannulae to the cardiopulmonary bypass elements may be optimized.
- a specific object of the present invention is to provide an extracorporeal flow circuit for use with endovascular cardiopulmonary bypass systems.
- a method of withdrawing blood from a patient and arresting the patient's heart is provided.
- An aortic occlusion device has an occluding member, a lumen and first and second branches coupled to the lumen.
- the first branch is coupled to a source of cardioplegic fluid, preferably blood cardioplegia
- the second branch is coupled to a pump, preferably a non-occlusive pump such as a centrifugal pump.
- a venous cannula is also coupled to the pump for withdrawing blood from the patient.
- the aortic occlusion device is then inserted into the patient so that the occluding member is positioned in the ascending aorta.
- An advantage of the present invention is that a single pump is used for withdrawing blood through the venous cannula and the aortic occlusion device.
- the single pump reduces the complexity of multi-pump systems.
- a venting catheter is passed through the patient's tricuspid and pulmonary valves and a venous cannula is positioned in an artery of the patient.
- the venting catheter and venous cannula are both coupled to a pump, preferably a non-occlusive pump such as a centrifugal pump.
- a pump preferably a non-occlusive pump such as a centrifugal pump.
- a method of withdrawing and returning blood to a patient supported by a bypass system is provided.
- a venous cannula is inserted into the venous system for withdrawing blood from the patient and an arterial cannula is inserted into the arterial system for returning blood to the patient.
- a venous line is coupled to the venous cannula and blood is withdrawn from the patient through the venous cannula and venous line.
- the venous cannula directs the blood to at least one pump which then pumps the blood through an arterial line to the arterial cannula.
- a blood storage element is coupled to the arterial line and is used to change the amount of blood in the perfusion circuit as needed.
- an outlet of the blood storage element is coupled to the venous line so that the blood storage element is in parallel with the pump.
- the first and second lumens are slidably coupled together.
- the blood storage element advantageously permits the perfusionist to actively adjust the amount of blood in the perfusion circuit by withdrawing or adding blood to the blood storage element using the pump.
- FIG. 1 shows a system for arresting a patient's heart and maintaining bypass support according to the present invention.
- FIG. 2 is a cross-sectional view of an aortic occlusion device and an arterial cannula around line A-A of FIG. 1.
- FIG. 3 is a cross-sectional view of a coronary sinus catheter about line B-B of FIG. 1.
- FIG. 4 shows a venous cannula and a venting catheter extending therethrough.
- FIG. 5 is a cross-sectional view of the venous cannula and venting catheter of FIG. 4 about line C-C.
- FIG. 6 shows a flow directing catheter used to direct the venting catheter.
- FIG. 7 is a cross-sectional view of the flow directing catheter and venting catheter of FIG. 6 about line D-D.
- FIG. 8 shows the distal tip of another preferred venting catheter.
- FIG. 9 is a cross-sectional view of the venting catheter of FIG. 8 about line E-E.
- FIG. 10 shows an obturator for use with the venting catheters of FIGS. 4 - 9 .
- FIG. 11 shows another system for arresting a patient's heart and maintaining bypass support according to the present invention.
- the cardiopulmonary bypass system includes an aortic occlusion device 2 , an endovascular coronary sinus catheter 4 , and an endovascular venting catheter 6 .
- Blood is withdrawn from the patient through a venous cannula 8 and returned to the patient through an arterial cannula 10 .
- the description of the invention begins with a discussion of the various catheters 2 , 4 , 6 and cannulae 8 , 10 of a preferred endovascular catheter and cannula system. Although the following describes a preferred endovascular system, other systems may be used without departing from the scope of the invention.
- the aortic occlusion device 2 preferably passes through the femoral artery or subclavian artery and into the ascending aorta.
- the catheter 2 has an occluding member 12 , which is preferably a balloon, for occluding the ascending aorta.
- the aortic occlusion device 2 has a first lumen 14 having an outlet distal to the occluding member 12 for delivering cardioplegic fluid to arrest the patient's heart.
- a second lumen 16 is coupled to a pressure monitor 13 to monitor pressure distal to the occluding member 12 and a third lumen 18 is coupled to a syringe 15 for delivering inflation fluid to the occluding member 12 .
- a member 20 which is wound in a helical manner, reinforces the catheter 2 .
- the second lumen 16 may be eliminated by monitoring pressure through the first lumen 14 or by providing a pressure transducer.
- the first lumen 14 of the aortic occlusion device 2 is fluidly coupled to a first branch 21 (see FIG. 1), which is used for perfusing cardioplegic fluid, and a second branch 23 (see FIG. 1), which is used for venting blood from the heart as will be described below.
- Aortic occlusion devices are described in U.S. Pat. Nos. 5,584,803, 5,478,309, and 5,433,700 and U.S. patent application Ser. No. 08/782,113, entitled “Muti-Lumen Catheter and Method of Manufacture,” filed Jan. 13, 1997, by inventors Timothy Corvi and John Stevens, which are all hereby incorporated by reference.
- the aortic occlusion device 2 preferably passes through a lumen 25 in the arterial cannula 10 in the manner described in U.S. Pat. Nos. 5,584,803 and 5,478,309 which are hereby incorporated by reference.
- the arterial cannula 10 also has a reinforcing member 27 wound in a helical manner and a preferred arterial cannula 10 is described in U.S. patent application Ser. No. 08/749,683, entitled “Cannula and Method of Manufacture and Use,” filed Nov. 15, 1996, by inventor David Snow, which is also hereby incorporated by reference.
- the aortic occlusion device 2 and the arterial cannula 10 may also be coupled together into a single, multi-channel catheter as described in U.S. Pat. No. 5,312,344, however, it is preferred to separate the aortic occlusion device 2 from the arterial cannula 10 for a number of reasons such as being able to replace the aortic occlusion device 2 without taking the patient off cardiopulmonary bypass.
- the aortic occlusion device 2 may also pass through a puncture in the ascending or descending aorta similar to the blood vessel occlusion trocar disclosed in U.S. Pat. No. 5,499,996.
- the coronary sinus catheter 4 is used for retrograde delivery of cardioplegic fluid via the coronary sinus.
- both antegrade and retrograde delivery of cardioplegic fluid are provided with the aortic occlusion device 2 providing antegrade perfusion and the coronary sinus catheter 4 providing retrograde perfusion.
- the coronary sinus catheter 4 preferably passes through the internal jugular vein, through the right atrium and into the coronary sinus.
- An occluding member 22 which is preferably a balloon, is used to occlude the coronary sinus. Referring to the cross-sectional view of FIG.
- a first lumen 24 is used for infusing cardioplegic fluid, preferably blood cardioplege
- a second lumen 26 is coupled to a pressure monitor 13
- a third lumen 28 is coupled to a syringe 15 for inflating the occluding member 22 .
- the first and second lumens 24 , 26 have outlets distal to the occluding member 22 for infusing cardioplege distal to the occluding member 22 and for measuring pressure distal to the occluding member 22 .
- Endovascular coronary sinus catheters are disclosed in U.S. Pat. No. 5,558,644 which is hereby incorporated by reference.
- the venting catheter 6 preferably extends through the internal jugular vein, through the right atrium, and through the tricuspid and pulmonary valves so that a distal tip 28 is in the pulmonary artery.
- the venting catheter 6 is used to decompress the heart through the pulmonary vasculature and to aid the venous cannula 8 in withdrawing blood from the patient.
- An advantage of the venting catheter 6 is that it partially opens the pulmonary and tricuspid valves to enhance blood removal through the venous cannula 8 .
- the venting catheter 6 can also be used as a diagnostic tool in that high flows through the venting catheter 6 may indicate a problem with the venous cannula 8 such as improper placement.
- venting catheter 6 A further description of the venting catheter 6 is provided below in connection with the description of FIGS. 8 and 9. Although it is preferred to provide a venting catheter 6 , venting of the pulmonary artery may also be accomplished using trocar, needle or the like which penetrates the wall of the pulmonary artery. Aortic occlusion devices, coronary sinus catheters, venting catheters, and arterial and venous cannulae may be purchased from Heartport, Inc. of Redwood City, Calif.
- FIGS. 4 and 5 another venting catheter 6 A and venous cannula 8 A are shown.
- the venting catheter 6 A extends through the venous cannula 8 A thereby eliminating the need for an independent access site for the venting catheter 6 A.
- the venous cannula 8 A has a lumen 32 which receives the venting catheter 6 A and a hemostasis valve (not shown) which seals the area between the venting catheter 6 A and venous cannula 8 A.
- the venous cannula 8 A also preferably has an opening 30 through which the venting catheter 6 A extends. Venous blood is withdrawn through openings 33 and pass through a line (not shown) connected to a barbed connector 34 .
- the venting catheter 6 A has a lumen 31 and openings 33 at a distal end for withdrawing blood from the pulmonary artery.
- a flow-directing catheter 36 having a flow-directing element 38 such as a balloon, may be used to help position the venting catheter 6 A.
- the flow-directing catheter 36 has a first lumen 37 and a second lumen 39 with one of the lumens being used to inflate the flow-directing element 38 and the other lumen either receiving a guidewire or being used for pressure measurement.
- a specialized obturator 41 having an angled tip 43 is used to direct the venting catheter 6 , 6 A through the opening 30 in the venous cannula 8 A.
- the venting catheter 6 has a flow-directing element 40 , such as a balloon, for directing the venting catheter 6 B through the tricuspid and pulmonary valves.
- the venting catheter 6 has a first lumen 42 for venting blood from the pulmonary artery, a second lumen 44 for monitoring pressure with the pressure monitor 13 or receiving a guidewire, and a third lumen 46 coupled to syringe 15 for inflating the flow-directing element 40 .
- the catheter may also have a shaped distal portion which is configured to direct the distal tip through the tricuspid and pulmonary valves.
- a preferred cardioplegic fluid is blood cardioplegia which contains a mixture of cardioplegic agent and blood. Blood is withdrawn from the extracorporeal bypass circuit, which will be described in greater detail below, combined with the cardioplegic agent, and delivered to the catheters with a roller pump 50 .
- a manifold 52 having valve operators 53 , 55 regulates the flow rate of cardioplegic fluid through cardioplege feed lines 54 , 56 leading to the catheters 2 , 4 .
- the pressure of the cardioplegic fluid being delivered to the patient's vascular system is measured to prevent overpressure.
- Pressure monitoring is particularly important when infusing the cardioplegic solution since overpressure can damage the blood and coronary vessels and can increase oxygen demand by distending the heart.
- the aortic occlusion device 2 , coronary sinus catheter 4 and venting catheter 6 all include lumens for pressure monitoring.
- a pressure monitor 58 also measures the delivery pressure of the cardioplege solution.
- the system may also include pressure alarms (not shown) which provide visual or audible signals when high or low pressure limits are reached.
- the endovascular cardiopulmonary bypass system described above withdraws blood from the patient through the venous cannula 8 , venting catheter 6 and aortic occlusion device 2 .
- the venous cannula 8 and venting catheter 6 are generally withdrawing blood throughout the bypass procedure while venting through the aortic occlusion device 2 is intermittent.
- a number of pumps typically roller pumps, would be used to accomplish these tasks.
- a single pump 60 preferably a centrifugal pump, is used to perform at least two, and preferably all three, of these tasks.
- roller pumps are positive displacement pumps which can create dangerously high negative and positive pressures. If a roller pump is used, it is preferred to provide a pressure relief valve or a pressure alarm to prevent overpressure.
- a pump controller 61 is used to control the pump. Preferred pumps include the Delphin by Sarns, the Lifestream by Bard, and the Biomedicus by Medtronic.
- the amount of blood being withdrawn through the catheters 2 , 6 and cannula 8 is regulated by valves 62 , 64 , 66 on a manifold 68 .
- the manifold 68 receives blood through a venous line 70 from the venous cannula 8 , a line 72 from the venting catheter 6 , and a vent line 74 from the aortic occlusion device 2 .
- the vent line 74 extends from the second branch 23 of the aortic occlusion device 2 which is fluidly coupled to the first lumen 14 .
- the valves 62 , 64 , 66 regulate flows through the aortic occlusion device 2 , venous cannula 8 and venting catheter 6 , respectively.
- the manifold 68 is preferably provided together with the various lines and catheters already connected together in a sterilized package.
- the lines 70 , 72 , 74 all merge into a common line 76 which has a connector 78 for connecting to a pump inlet 80 .
- an advantage of the present system is that only one connection is required to couple the catheters and cannula to the pump inlet 80 after the catheters and cannulae are removed from the sterilized packaging.
- the present invention provides clear advantages over conventional perfusion circuits by eliminating the number of connections between catheters, cannulae and the various pumps thereby reducing the set-up time.
- oxygentor/heat exchanger 86 which is preferably a membrane-type oxygenator/heat exchanger, and through a filter/bubble trap 88 and is returned to the patient through the arterial cannula 10 .
- Preferred oxygenator/heat exchangers 86 include the Affinity by Avecor and the Maxima by Medtronic.
- the filter/bubble trap 88 may be dispensed with if the oxygenator/heat exchanger 86 is capable of performing the functions of the filter/bubble trap 88 . If a separate filter/bubble trap 88 is used preferred filter/bubble traps include the H-690 by Bard and the AF1040D by Baxter.
- Another advantage of the present system is that the system is closed and does not have an air/blood contact surface which generally occurs when using open cardiotomy reservoirs. Reducing or eliminating air/blood contact advantageously reduces complement activation and other humoral mediated response mechanisms.
- Another benefit of the present invention is a reduced priming volume as compared to conventional systems having open cardiotomy reservoirs. A reduced priming volume will reduce hemodilution and will result in higher hematocrits and, thus, more oxygen carrying capacity and buffering capability. A reduction in blood clotting factor dilution may also reduce bleeding complications.
- a blood storage element 90 Fluctuations in the volume of blood handled by the perfusion system are accommodated with a blood storage element 90 .
- the volume of blood in the extracorporeal circuit may increase or decrease throughout the procedure.
- blood in the circuit may be lost to field suction or blood may be added to the circuit when it is desired to reduce the blood volume in the patient.
- the blood storage element 90 provides the perfusionist with the flexibility to change the blood volume in the perfusion circuit for these and other purposes.
- the blood storage element 90 may be any type of storage element 90 and is preferably a collapsible bag such as the BMR 1900 by Baxter.
- the blood storage element 90 is preferably configured in parallel with the pump 60 , however, it may also be configured in series with the pump 60 .
- Valves 92 , 94 and valve 96 which is preferably mounted to the manifold 68 , regulate flow through the blood storage element 90 .
- valves 92 , 94 , 96 are preferred, clamps may also be used instead of valves, however, valves 92 , 94 , 96 are preferred so that the flow rate into and out of the blood storage element 90 may be regulated.
- the valves 92 , 94 , 96 are particularly useful for providing a low, continuous flow through the blood storage element to minimize clotting of stagnant blood.
- a syringe 98 filled with heparin may also provided to reduce clotting in the blood storage element 90 .
- the entire perfusion circuit and all of the catheters and cannulae disclosed herein may be coated with a biocompatible coating, such as Duraflo II by Baxter or Cameda by Medtronic, to reduce clotting and damage to the blood.
- a field suction device 100 for clearing the surgical field of blood, is coupled to a conventional cardiotomy reservoir 102 .
- An IV bag 104 is also coupled to the cardiotomy reservoir 102 and a regulated wall vacuum 106 is used to draw fluid into the cardiotomy reservoir 102 .
- a make-up line 108 leads from the cardiotomy resesrvoir 102 to the common line 76 and is used to draw blood into the perfusion system if required.
- Another source of blood 110 and a filter 111 are coupled to the common line 76 to add blood to the perfusion circuit, if required, or to prime the system.
- a bridge line 112 extends between the arterial line 84 and venous line 70 for recirculating blood through the perfusion circuit and bypassing the patient.
- Clamps 114 , 116 are closed to isolate the patient from the perfusion circuit and clamp 118 is opened to isolate the patient and recirculate blood in the perfusion circuit.
- the bridge line 112 is particularly useful in removing air from the perfusion circuit. If air is introduced in the circuit, clamps 114 , 116 are closed, thereby isolating the patient from the circuit, and clamp 118 is opened to permit circulation of blood in the perfusion circuit. Blood is then circulated through the circuit until the air is removed through the oxygenator/heat exchanger 86 and bubble trap/filter 88 .
- Clamp 118 may also have a partially open position so that a small flow of blood passes through the clamp 118 to reduce clotting of stagnant blood in the bridge line 112 .
- FIG. 11 another preferred bypass circuit is shown with like reference numerals referring to like structures.
- the bypass circuit has the venting catheter 6 A extending through the venous cannula 8 A, as described above, which advantageously reduces the number of openings in the patient's vascular system.
- the occluding members can be an expandable member other than a balloon
- the blood storage element and the bridge line may be dispensed with
- the access sites for the various catheters and cannulae may be from any other suitable vein or artery.
- the term “fluidly coupled” as used herein does not require a direct connection but, rather, a fluid communication between elements which may be through pipes, hoses, filters, valve and the like. Therefore, the above description should not be taken as limiting the scope of the invention which is defined by the claims.
Abstract
Description
- This application is a division of co-pending application Ser. No. 08/789,223, filed Jan. 24, 1997, the complete disclosure of all of which is hereby incorporated herein by reference for all purposes.
- The present invention relates to systems for arresting a patient's heart and maintaining a patient on cardiopulmonary bypass. Such systems are used when performing surgical procedures, such as coronary artery bypass grafting, on an arrested heart.
- In conventional open-heart surgery, the patient's breast bone is sawed open, the chest is spread apart, and the heart is accessed through the large opening created in the patient's chest. The patient is placed on cardiopulmonary bypass and the patient's heart is then arrested using catheters and cannulae which are inserted directly into the large arteries and veins attached to the heart through the large opening in the chest. The arterial cannula typically passes through the wall of the ascending aorta and a cross-clamp is applied to the ascending aorta to isolate the coronary arteries from the remainder of the arterial system. A venous cannula passes through the right atrium for withdrawing blood from the patient.
- Recent developments in cardiac surgery have enabled surgeons to perform coronary artery bypass grafting and valve repair and replacement procedures without creating a large opening in the patient's chest. These developments have significantly reduced trauma to the patient by eliminating the need for sawing open the breast bone and opening the patient's chest. Such procedures are disclosed in U.S. Pat. Nos. 5,452,733 and 5,571,215 which are hereby incorporated by reference.
- In order to perform such surgical procedures, the patient's heart must be arrested and the patient placed on cardiopulmonary bypass without direct access to the heart. Catheters and cannulae for arresting the patient's heart and establishing bypass without requiring direct access to the patient's heart are disclosed in U.S. Pat. Nos. 5,584,803 and 5,558,644 which are hereby incorporated by reference.
- The systems described in U.S. Pat. Nos. 5,584,803 and 5,558,644 include an aortic occlusion device which has a balloon to occlude the ascending aorta and a lumen to deliver cardioplegic fluid for arresting the patient's heart. The aortic occlusion device replaces the conventional external cross-clamp and advantageously reduces the amount of displacement and distortion of the aorta. Minimizing distortion of the aorta may reduce the amount of emboli released and, therefore, may reduce stroke incidents.
- A venous cannula withdraws blood from the patient and blood is returned to the patient through an arterial cannula which is placed at a peripheral artery such as the femoral artery. In a preferred embodiment, the aortic occlusion device passes through the arterial cannula thereby minimizing the number of penetrations in the patients vascular system.
- The systems described in U.S. Pat. Nos. 5,584,803 and 5,558,644 also include an endovascular coronary sinus catheter for retrograde perfusion of a cardioplegic agent, preferably blood cardioplegia, via the coronary sinus. The coronary sinus catheter preferably passes through the internal jugular vein and has an inflatable balloon for occluding the coronary sinus. An endovascular venting catheter extends through the tricuspid and pulmonary valves for venting the pulmonary artery.
- Although the endovascular bypass system has performed admirably and has enabled surgeons to perform less invasive cardiac procedures, the extracorporeal bypass circuit which couples the catheters and cannulae to the cardiopulmonary bypass elements may be optimized.
- Thus, a specific object of the present invention is to provide an extracorporeal flow circuit for use with endovascular cardiopulmonary bypass systems.
- In accordance with the present invention, methods and devices for maintaining cardiopulmonary bypass support and arresting the patient's heart are provided.
- In a first aspect of the invention, a method of withdrawing blood from a patient and arresting the patient's heart is provided. An aortic occlusion device has an occluding member, a lumen and first and second branches coupled to the lumen. The first branch is coupled to a source of cardioplegic fluid, preferably blood cardioplegia, and the second branch is coupled to a pump, preferably a non-occlusive pump such as a centrifugal pump. A venous cannula is also coupled to the pump for withdrawing blood from the patient. The aortic occlusion device is then inserted into the patient so that the occluding member is positioned in the ascending aorta. The occluding member is then expanded to occlude the ascending aorta and cardioplegic fluid is delivered through the lumen in the aortic occlusion device to arrest the patient's heart. An advantage of the present invention is that a single pump is used for withdrawing blood through the venous cannula and the aortic occlusion device. The single pump reduces the complexity of multi-pump systems.
- In another aspect of the present invention, another method of withdrawing blood from the patient is provided. A venting catheter is passed through the patient's tricuspid and pulmonary valves and a venous cannula is positioned in an artery of the patient. The venting catheter and venous cannula are both coupled to a pump, preferably a non-occlusive pump such as a centrifugal pump. An advantage of coupling the venous cannula and venting catheter to the same pump is that the system becomes self-regulating in that blood is withdrawn through the venous cannula when low flows are achieved through the vent catheter.
- In yet another aspect of the invention, a method of withdrawing and returning blood to a patient supported by a bypass system is provided. A venous cannula is inserted into the venous system for withdrawing blood from the patient and an arterial cannula is inserted into the arterial system for returning blood to the patient. A venous line is coupled to the venous cannula and blood is withdrawn from the patient through the venous cannula and venous line. The venous cannula directs the blood to at least one pump which then pumps the blood through an arterial line to the arterial cannula. A blood storage element is coupled to the arterial line and is used to change the amount of blood in the perfusion circuit as needed. In a preferred aspect of the method, an outlet of the blood storage element is coupled to the venous line so that the blood storage element is in parallel with the pump. In another preferred aspect of the invention, the first and second lumens are slidably coupled together. The blood storage element advantageously permits the perfusionist to actively adjust the amount of blood in the perfusion circuit by withdrawing or adding blood to the blood storage element using the pump.
- These and other aspects of the invention will become apparent from the following description of the preferred embodiments.
- FIG. 1 shows a system for arresting a patient's heart and maintaining bypass support according to the present invention.
- FIG. 2 is a cross-sectional view of an aortic occlusion device and an arterial cannula around line A-A of FIG. 1.
- FIG. 3 is a cross-sectional view of a coronary sinus catheter about line B-B of FIG. 1.
- FIG. 4 shows a venous cannula and a venting catheter extending therethrough.
- FIG. 5 is a cross-sectional view of the venous cannula and venting catheter of FIG. 4 about line C-C.
- FIG. 6 shows a flow directing catheter used to direct the venting catheter.
- FIG. 7 is a cross-sectional view of the flow directing catheter and venting catheter of FIG. 6 about line D-D.
- FIG. 8 shows the distal tip of another preferred venting catheter.
- FIG. 9 is a cross-sectional view of the venting catheter of FIG. 8 about line E-E.
- FIG. 10 shows an obturator for use with the venting catheters of FIGS.4-9.
- FIG. 11 shows another system for arresting a patient's heart and maintaining bypass support according to the present invention.
- Referring to FIG. 1, a cardiopulmonary bypass system according to the present invention is shown. The cardiopulmonary bypass system includes an
aortic occlusion device 2, an endovascularcoronary sinus catheter 4, and anendovascular venting catheter 6. Blood is withdrawn from the patient through avenous cannula 8 and returned to the patient through anarterial cannula 10. The description of the invention begins with a discussion of thevarious catheters cannulae - The
aortic occlusion device 2 preferably passes through the femoral artery or subclavian artery and into the ascending aorta. Thecatheter 2 has an occludingmember 12, which is preferably a balloon, for occluding the ascending aorta. Referring to the cross-sectional view of FIG. 2, theaortic occlusion device 2 has afirst lumen 14 having an outlet distal to the occludingmember 12 for delivering cardioplegic fluid to arrest the patient's heart. Asecond lumen 16 is coupled to apressure monitor 13 to monitor pressure distal to the occludingmember 12 and athird lumen 18 is coupled to asyringe 15 for delivering inflation fluid to the occludingmember 12. Amember 20, which is wound in a helical manner, reinforces thecatheter 2. Thesecond lumen 16 may be eliminated by monitoring pressure through thefirst lumen 14 or by providing a pressure transducer. Thefirst lumen 14 of theaortic occlusion device 2 is fluidly coupled to a first branch 21 (see FIG. 1), which is used for perfusing cardioplegic fluid, and a second branch 23 (see FIG. 1), which is used for venting blood from the heart as will be described below. Aortic occlusion devices are described in U.S. Pat. Nos. 5,584,803, 5,478,309, and 5,433,700 and U.S. patent application Ser. No. 08/782,113, entitled “Muti-Lumen Catheter and Method of Manufacture,” filed Jan. 13, 1997, by inventors Timothy Corvi and John Stevens, which are all hereby incorporated by reference. - Still referring to FIG. 2, the
aortic occlusion device 2 preferably passes through alumen 25 in thearterial cannula 10 in the manner described in U.S. Pat. Nos. 5,584,803 and 5,478,309 which are hereby incorporated by reference. Thearterial cannula 10 also has a reinforcingmember 27 wound in a helical manner and a preferredarterial cannula 10 is described in U.S. patent application Ser. No. 08/749,683, entitled “Cannula and Method of Manufacture and Use,” filed Nov. 15, 1996, by inventor David Snow, which is also hereby incorporated by reference. Theaortic occlusion device 2 and thearterial cannula 10 may also be coupled together into a single, multi-channel catheter as described in U.S. Pat. No. 5,312,344, however, it is preferred to separate theaortic occlusion device 2 from thearterial cannula 10 for a number of reasons such as being able to replace theaortic occlusion device 2 without taking the patient off cardiopulmonary bypass. Theaortic occlusion device 2 may also pass through a puncture in the ascending or descending aorta similar to the blood vessel occlusion trocar disclosed in U.S. Pat. No. 5,499,996. - The
coronary sinus catheter 4 is used for retrograde delivery of cardioplegic fluid via the coronary sinus. Thus, both antegrade and retrograde delivery of cardioplegic fluid are provided with theaortic occlusion device 2 providing antegrade perfusion and thecoronary sinus catheter 4 providing retrograde perfusion. Thecoronary sinus catheter 4 preferably passes through the internal jugular vein, through the right atrium and into the coronary sinus. An occludingmember 22, which is preferably a balloon, is used to occlude the coronary sinus. Referring to the cross-sectional view of FIG. 3, afirst lumen 24 is used for infusing cardioplegic fluid, preferably blood cardioplege, asecond lumen 26 is coupled to apressure monitor 13 and athird lumen 28 is coupled to asyringe 15 for inflating the occludingmember 22. The first andsecond lumens member 22 for infusing cardioplege distal to the occludingmember 22 and for measuring pressure distal to the occludingmember 22. Endovascular coronary sinus catheters are disclosed in U.S. Pat. No. 5,558,644 which is hereby incorporated by reference. - The venting
catheter 6 preferably extends through the internal jugular vein, through the right atrium, and through the tricuspid and pulmonary valves so that adistal tip 28 is in the pulmonary artery. The ventingcatheter 6 is used to decompress the heart through the pulmonary vasculature and to aid thevenous cannula 8 in withdrawing blood from the patient. An advantage of the ventingcatheter 6 is that it partially opens the pulmonary and tricuspid valves to enhance blood removal through thevenous cannula 8. The ventingcatheter 6 can also be used as a diagnostic tool in that high flows through the ventingcatheter 6 may indicate a problem with thevenous cannula 8 such as improper placement. A further description of the ventingcatheter 6 is provided below in connection with the description of FIGS. 8 and 9. Although it is preferred to provide a ventingcatheter 6, venting of the pulmonary artery may also be accomplished using trocar, needle or the like which penetrates the wall of the pulmonary artery. Aortic occlusion devices, coronary sinus catheters, venting catheters, and arterial and venous cannulae may be purchased from Heartport, Inc. of Redwood City, Calif. - Referring to FIGS. 4 and 5, another venting
catheter 6A andvenous cannula 8A are shown. The ventingcatheter 6A extends through thevenous cannula 8A thereby eliminating the need for an independent access site for the ventingcatheter 6A. Thevenous cannula 8A has alumen 32 which receives the ventingcatheter 6A and a hemostasis valve (not shown) which seals the area between the ventingcatheter 6A andvenous cannula 8A. Thevenous cannula 8A also preferably has anopening 30 through which theventing catheter 6A extends. Venous blood is withdrawn throughopenings 33 and pass through a line (not shown) connected to abarbed connector 34. The ventingcatheter 6A has a lumen 31 andopenings 33 at a distal end for withdrawing blood from the pulmonary artery. Referring to FIGS. 6 and 7, a flow-directingcatheter 36 having a flow-directing element 38, such as a balloon, may be used to help position the ventingcatheter 6A. The flow-directingcatheter 36 has afirst lumen 37 and asecond lumen 39 with one of the lumens being used to inflate the flow-directing element 38 and the other lumen either receiving a guidewire or being used for pressure measurement. Referring to FIG. 10, aspecialized obturator 41 having anangled tip 43 is used to direct the ventingcatheter opening 30 in thevenous cannula 8A. - Referring to FIGS. 1, 8 and9, the venting
catheter 6 has a flow-directingelement 40, such as a balloon, for directing the ventingcatheter 6B through the tricuspid and pulmonary valves. The ventingcatheter 6 has afirst lumen 42 for venting blood from the pulmonary artery, asecond lumen 44 for monitoring pressure with the pressure monitor 13 or receiving a guidewire, and athird lumen 46 coupled tosyringe 15 for inflating the flow-directingelement 40. The catheter may also have a shaped distal portion which is configured to direct the distal tip through the tricuspid and pulmonary valves. - Referring again to FIG. 1, the
aortic occlusion device 2 andcoronary sinus catheter 4 are both coupled to a source ofcardioplegic fluid 48. A preferred cardioplegic fluid is blood cardioplegia which contains a mixture of cardioplegic agent and blood. Blood is withdrawn from the extracorporeal bypass circuit, which will be described in greater detail below, combined with the cardioplegic agent, and delivered to the catheters with aroller pump 50. A manifold 52 havingvalve operators cardioplege feed lines catheters - The pressure of the cardioplegic fluid being delivered to the patient's vascular system is measured to prevent overpressure. Pressure monitoring is particularly important when infusing the cardioplegic solution since overpressure can damage the blood and coronary vessels and can increase oxygen demand by distending the heart. As mentioned above, the
aortic occlusion device 2,coronary sinus catheter 4 and ventingcatheter 6 all include lumens for pressure monitoring. A pressure monitor 58 also measures the delivery pressure of the cardioplege solution. The system may also include pressure alarms (not shown) which provide visual or audible signals when high or low pressure limits are reached. - The endovascular cardiopulmonary bypass system described above withdraws blood from the patient through the
venous cannula 8, ventingcatheter 6 andaortic occlusion device 2. Thevenous cannula 8 and ventingcatheter 6 are generally withdrawing blood throughout the bypass procedure while venting through theaortic occlusion device 2 is intermittent. In many conventional perfusion circuits, a number of pumps, typically roller pumps, would be used to accomplish these tasks. In accordance with the present invention, asingle pump 60, preferably a centrifugal pump, is used to perform at least two, and preferably all three, of these tasks. It is preferred to use a centrifugal pump rather than a roller pump since roller pumps are positive displacement pumps which can create dangerously high negative and positive pressures. If a roller pump is used, it is preferred to provide a pressure relief valve or a pressure alarm to prevent overpressure. Another advantage of using thesingle pump 60 is ease of operation since the user must concentrate on only one pump rather than three or more. Apump controller 61 is used to control the pump. Preferred pumps include the Delphin by Sarns, the Lifestream by Bard, and the Biomedicus by Medtronic. - The amount of blood being withdrawn through the
catheters cannula 8 is regulated byvalves manifold 68. The manifold 68 receives blood through avenous line 70 from thevenous cannula 8, aline 72 from the ventingcatheter 6, and avent line 74 from theaortic occlusion device 2. Thevent line 74 extends from thesecond branch 23 of theaortic occlusion device 2 which is fluidly coupled to thefirst lumen 14. Thevalves aortic occlusion device 2,venous cannula 8 and ventingcatheter 6, respectively. The manifold 68 is preferably provided together with the various lines and catheters already connected together in a sterilized package. Thelines common line 76 which has aconnector 78 for connecting to a pump inlet 80. Thus, an advantage of the present system is that only one connection is required to couple the catheters and cannula to the pump inlet 80 after the catheters and cannulae are removed from the sterilized packaging. The present invention provides clear advantages over conventional perfusion circuits by eliminating the number of connections between catheters, cannulae and the various pumps thereby reducing the set-up time. - After passing through the
pump 60, blood passes through apump outlet 82 and into anarterial line 84. Thearterial line 84 passes through an oxygentor/heat exchanger 86, which is preferably a membrane-type oxygenator/heat exchanger, and through a filter/bubble trap 88 and is returned to the patient through thearterial cannula 10. Preferred oxygenator/heat exchangers 86 include the Affinity by Avecor and the Maxima by Medtronic. The filter/bubble trap 88 may be dispensed with if the oxygenator/heat exchanger 86 is capable of performing the functions of the filter/bubble trap 88. If a separate filter/bubble trap 88 is used preferred filter/bubble traps include the H-690 by Bard and the AF1040D by Baxter. - Another advantage of the present system is that the system is closed and does not have an air/blood contact surface which generally occurs when using open cardiotomy reservoirs. Reducing or eliminating air/blood contact advantageously reduces complement activation and other humoral mediated response mechanisms. Another benefit of the present invention is a reduced priming volume as compared to conventional systems having open cardiotomy reservoirs. A reduced priming volume will reduce hemodilution and will result in higher hematocrits and, thus, more oxygen carrying capacity and buffering capability. A reduction in blood clotting factor dilution may also reduce bleeding complications.
- Fluctuations in the volume of blood handled by the perfusion system are accommodated with a
blood storage element 90. When a patient is on cardiopulmonary bypass, the volume of blood in the extracorporeal circuit may increase or decrease throughout the procedure. For example, blood in the circuit may be lost to field suction or blood may be added to the circuit when it is desired to reduce the blood volume in the patient. Theblood storage element 90 provides the perfusionist with the flexibility to change the blood volume in the perfusion circuit for these and other purposes. Theblood storage element 90 may be any type ofstorage element 90 and is preferably a collapsible bag such as the BMR 1900 by Baxter. - The
blood storage element 90 is preferably configured in parallel with thepump 60, however, it may also be configured in series with thepump 60.Valves valve 96, which is preferably mounted to the manifold 68, regulate flow through theblood storage element 90. Althoughvalves valves blood storage element 90 may be regulated. Thevalves syringe 98 filled with heparin may also provided to reduce clotting in theblood storage element 90. Furthermore, the entire perfusion circuit and all of the catheters and cannulae disclosed herein may be coated with a biocompatible coating, such as Duraflo II by Baxter or Cameda by Medtronic, to reduce clotting and damage to the blood. - A
field suction device 100, for clearing the surgical field of blood, is coupled to aconventional cardiotomy reservoir 102. AnIV bag 104 is also coupled to thecardiotomy reservoir 102 and aregulated wall vacuum 106 is used to draw fluid into thecardiotomy reservoir 102. A make-upline 108 leads from the cardiotomy resesrvoir 102 to thecommon line 76 and is used to draw blood into the perfusion system if required. Another source ofblood 110 and afilter 111 are coupled to thecommon line 76 to add blood to the perfusion circuit, if required, or to prime the system. - A
bridge line 112 extends between thearterial line 84 andvenous line 70 for recirculating blood through the perfusion circuit and bypassing the patient.Clamps bridge line 112 is particularly useful in removing air from the perfusion circuit. If air is introduced in the circuit, clamps 114, 116 are closed, thereby isolating the patient from the circuit, and clamp 118 is opened to permit circulation of blood in the perfusion circuit. Blood is then circulated through the circuit until the air is removed through the oxygenator/heat exchanger 86 and bubble trap/filter 88.Clamp 118 may also have a partially open position so that a small flow of blood passes through theclamp 118 to reduce clotting of stagnant blood in thebridge line 112. - Referring to FIG. 11, another preferred bypass circuit is shown with like reference numerals referring to like structures. The bypass circuit has the venting
catheter 6A extending through thevenous cannula 8A, as described above, which advantageously reduces the number of openings in the patient's vascular system. - While the above is a preferred description of the invention, various alternatives, modifications and equivalents may be used without departing from the scope of the invention. For example, the occluding members can be an expandable member other than a balloon, the blood storage element and the bridge line may be dispensed with, and the access sites for the various catheters and cannulae may be from any other suitable vein or artery. Furthermore, the term “fluidly coupled” as used herein does not require a direct connection but, rather, a fluid communication between elements which may be through pipes, hoses, filters, valve and the like. Therefore, the above description should not be taken as limiting the scope of the invention which is defined by the claims.
Claims (20)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/401,734 US6443922B1 (en) | 1997-01-24 | 1999-09-23 | Methods and devices for maintaining cardiopulmonary bypass and arresting a patient's heart |
US10/193,627 US6974434B2 (en) | 1997-01-24 | 2002-07-11 | Methods and devices for maintaining cardiopulmonary bypass and arresting a patient's heart |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/789,223 US5957879A (en) | 1997-01-24 | 1997-01-24 | Methods and devices for maintaining cardiopulmonary bypass and arresting a patient's heart |
US09/401,734 US6443922B1 (en) | 1997-01-24 | 1999-09-23 | Methods and devices for maintaining cardiopulmonary bypass and arresting a patient's heart |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/789,223 Division US5957879A (en) | 1997-01-24 | 1997-01-24 | Methods and devices for maintaining cardiopulmonary bypass and arresting a patient's heart |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/193,627 Division US6974434B2 (en) | 1997-01-24 | 2002-07-11 | Methods and devices for maintaining cardiopulmonary bypass and arresting a patient's heart |
Publications (2)
Publication Number | Publication Date |
---|---|
US20020087107A1 true US20020087107A1 (en) | 2002-07-04 |
US6443922B1 US6443922B1 (en) | 2002-09-03 |
Family
ID=25146969
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/789,223 Expired - Lifetime US5957879A (en) | 1997-01-24 | 1997-01-24 | Methods and devices for maintaining cardiopulmonary bypass and arresting a patient's heart |
US09/401,734 Expired - Lifetime US6443922B1 (en) | 1997-01-24 | 1999-09-23 | Methods and devices for maintaining cardiopulmonary bypass and arresting a patient's heart |
US10/193,627 Expired - Fee Related US6974434B2 (en) | 1997-01-24 | 2002-07-11 | Methods and devices for maintaining cardiopulmonary bypass and arresting a patient's heart |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/789,223 Expired - Lifetime US5957879A (en) | 1997-01-24 | 1997-01-24 | Methods and devices for maintaining cardiopulmonary bypass and arresting a patient's heart |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/193,627 Expired - Fee Related US6974434B2 (en) | 1997-01-24 | 2002-07-11 | Methods and devices for maintaining cardiopulmonary bypass and arresting a patient's heart |
Country Status (1)
Country | Link |
---|---|
US (3) | US5957879A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060155237A1 (en) * | 2004-11-18 | 2006-07-13 | Venkataramana Vijay | Integrated cardiopulmonary bypass system for open and closed bypass circuits |
US7238165B2 (en) | 2002-02-21 | 2007-07-03 | Design Mentor, Inc. | Fluid pump |
WO2012071413A2 (en) * | 2010-11-23 | 2012-05-31 | The Trustees Of Columbia University In The City Of New York | Assembly and method for coronary sinus cannulation |
WO2016119771A3 (en) * | 2015-01-26 | 2016-10-20 | Xenios Ag | Assembly comprising a suction line, a pressure line and a pump |
Families Citing this family (92)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7678098B2 (en) * | 1996-04-10 | 2010-03-16 | Endoscopic Technologies, Inc. | Venous cannula and cardiopulmonary bypass system |
WO1997042879A1 (en) * | 1996-05-14 | 1997-11-20 | Embol-X, Inc. | Aortic occluder with associated filter and methods of use during cardiac surgery |
US6022336A (en) | 1996-05-20 | 2000-02-08 | Percusurge, Inc. | Catheter system for emboli containment |
US6440146B2 (en) | 1996-07-23 | 2002-08-27 | United States Surgical Corporation | Anastomosis instrument and method |
US5957879A (en) * | 1997-01-24 | 1999-09-28 | Heartport, Inc. | Methods and devices for maintaining cardiopulmonary bypass and arresting a patient's heart |
CA2322876A1 (en) | 1997-03-06 | 1998-09-11 | Percusurge, Inc. | Intravascular aspiration system |
US6315751B1 (en) * | 1997-08-15 | 2001-11-13 | Cleveland Clinic Foundation | Cardiopulmonary bypass system using vacuum assisted venous drainage |
US7371254B2 (en) | 1998-01-23 | 2008-05-13 | Innercool Therapies, Inc. | Medical procedure |
US6491039B1 (en) | 1998-01-23 | 2002-12-10 | Innercool Therapies, Inc. | Medical procedure |
US6622367B1 (en) | 1998-02-03 | 2003-09-23 | Salient Interventional Systems, Inc. | Intravascular device and method of manufacture and use |
US6295990B1 (en) | 1998-02-03 | 2001-10-02 | Salient Interventional Systems, Inc. | Methods and systems for treating ischemia |
US20010027287A1 (en) * | 1998-05-26 | 2001-10-04 | Trans Vascular, Inc. | Apparatus for providing coronary retroperfusion and/or left ventricular assist and methods of use |
US6632189B1 (en) * | 1998-09-18 | 2003-10-14 | Edwards Lifesciences Corporation | Support device for surgical systems |
US6554790B1 (en) * | 1998-11-20 | 2003-04-29 | Intuitive Surgical, Inc. | Cardiopulmonary bypass device and method |
CA2356993C (en) | 1999-01-04 | 2009-06-23 | Medivance, Inc. | Improved cooling/heating pad and system |
US6306346B1 (en) * | 1999-02-10 | 2001-10-23 | Terumo Cardiovascular Systems Corporation | Self-contained pack assembly for an extracorporeal blood circuit |
US6468473B1 (en) | 1999-02-10 | 2002-10-22 | Terumo Cardiovascular Systems Corporation | Self-contained pack assembly for an extracorporeal blood circuit |
US6626930B1 (en) * | 1999-10-21 | 2003-09-30 | Edwards Lifesciences Corporation | Minimally invasive mitral valve repair method and apparatus |
JP2003517870A (en) * | 1999-12-22 | 2003-06-03 | ボストン サイエンティフィック リミテッド | Endovascular occlusion irrigation catheter and its use |
DE60127236T2 (en) | 2000-01-18 | 2007-11-22 | Tyco Healthcare Group Lp, Norwalk | Instrument for anastomosis |
EP1267760A2 (en) | 2000-03-31 | 2003-01-02 | Innercool Therapies, Inc. | Medical procedure |
US7083628B2 (en) | 2002-09-03 | 2006-08-01 | Edwards Lifesciences Corporation | Single catheter mitral valve repair device and method for use |
US6746426B1 (en) * | 2000-07-11 | 2004-06-08 | Medtronic Vascular, Inc. | Transluminally deliverable vascular blockers and methods for facilitating retrograde flow of arterial blood through veins |
SE0002878D0 (en) * | 2000-08-11 | 2000-08-11 | Kimblad Ola | Device and method of treatment of atrioventricular regurgitation |
US6808508B1 (en) * | 2000-09-13 | 2004-10-26 | Cardiacassist, Inc. | Method and system for closed chest blood flow support |
US8323228B2 (en) | 2007-04-12 | 2012-12-04 | Rex Medical L.P. | Dialysis catheter |
US6814718B2 (en) | 2001-01-09 | 2004-11-09 | Rex Medical, L.P | Dialysis catheter |
WO2002058568A1 (en) * | 2001-01-24 | 2002-08-01 | Tyco Healthcare Group Lp | Anastomosis instrument and method for performing same |
US20020107531A1 (en) * | 2001-02-06 | 2002-08-08 | Schreck Stefan G. | Method and system for tissue repair using dual catheters |
JP2003111848A (en) * | 2001-10-05 | 2003-04-15 | Nihon Medix | Heated balloon catheter device and its heating method |
US6660027B2 (en) | 2001-10-11 | 2003-12-09 | Medivance Incorporated | Patient temperature control system with fluid preconditioning |
US6699267B2 (en) | 2001-10-11 | 2004-03-02 | Medivance Incorporated | Patient temperature control system with fluid temperature response |
US6818012B2 (en) | 2001-10-11 | 2004-11-16 | Medivance, Incorporated | Patient temperature control system with fluid temperature response |
US20070160645A1 (en) * | 2001-10-25 | 2007-07-12 | Jakob Vinten-Johansen | PostConditioning System And Method For The Reduction Of Ischemic-Reperfusion Injury In The Heart And Other Organs |
WO2003035142A2 (en) | 2001-10-25 | 2003-05-01 | Emory University | Catheter for modified perfusion |
US6758836B2 (en) * | 2002-02-07 | 2004-07-06 | C. R. Bard, Inc. | Split tip dialysis catheter |
US6692518B2 (en) | 2002-02-27 | 2004-02-17 | Medivance Incorporated | Patient temperature control system |
US7094244B2 (en) * | 2002-03-26 | 2006-08-22 | Edwards Lifesciences Corporation | Sequential heart valve leaflet repair device and method of use |
US6769594B2 (en) | 2002-05-31 | 2004-08-03 | Tyco Healthcare Group, Lp | End-to-end anastomosis instrument and method for performing same |
US6893414B2 (en) * | 2002-08-12 | 2005-05-17 | Breg, Inc. | Integrated infusion and aspiration system and method |
US7022372B1 (en) | 2002-11-12 | 2006-04-04 | Advanced Cardiovascular Systems, Inc. | Compositions for coating implantable medical devices |
US7201870B2 (en) | 2003-01-14 | 2007-04-10 | Medtronic, Inc. | Active air removal system operating modes of an extracorporeal blood circuit |
US7204958B2 (en) | 2003-01-14 | 2007-04-17 | Medtronic, Inc. | Extracorporeal blood circuit air removal system and method |
US7335334B2 (en) | 2003-01-14 | 2008-02-26 | Medtronic, Inc. | Active air removal from an extracorporeal blood circuit |
US7393339B2 (en) | 2003-02-21 | 2008-07-01 | C. R. Bard, Inc. | Multi-lumen catheter with separate distal tips |
US7563483B2 (en) | 2003-02-26 | 2009-07-21 | Advanced Cardiovascular Systems Inc. | Methods for fabricating a coating for implantable medical devices |
US6926919B1 (en) | 2003-02-26 | 2005-08-09 | Advanced Cardiovascular Systems, Inc. | Method for fabricating a coating for a medical device |
US7381210B2 (en) | 2003-03-14 | 2008-06-03 | Edwards Lifesciences Corporation | Mitral valve repair system and method for use |
US20050085762A1 (en) * | 2003-03-31 | 2005-04-21 | Venkataramana Vijay | Perfusion circuit for cardiopulmonary bypass with air removal system |
US6946099B2 (en) * | 2003-03-31 | 2005-09-20 | Venkataramana Vijay | Methods of using condensed perfusion circuit for cardiopulmonary bypass and cardioplegia |
US6852280B2 (en) * | 2003-03-31 | 2005-02-08 | Venkataramana Vijay | Condensed perfusion circuit for cardiopulmonary bypass and cardioplegia |
US20040243095A1 (en) | 2003-05-27 | 2004-12-02 | Shekhar Nimkar | Methods and apparatus for inserting multi-lumen spit-tip catheters into a blood vessel |
US20050010241A1 (en) * | 2003-07-09 | 2005-01-13 | Keith Milliman | Anastomosis instrument and method for performing same |
US20060269444A1 (en) * | 2003-07-11 | 2006-11-30 | Tomislav Mihaljevic | Cardioscopy |
AU2003279527A1 (en) * | 2003-10-07 | 2005-04-21 | Arcamedica S.R.L. | Hameoperfusion apparatus for use during cardiac and/or vascular operative procedures |
US8992454B2 (en) | 2004-06-09 | 2015-03-31 | Bard Access Systems, Inc. | Splitable tip catheter with bioresorbable adhesive |
US20060004316A1 (en) | 2004-07-02 | 2006-01-05 | Difiore Attilio E | Reduction of recirculation in catheters |
US8323227B2 (en) | 2004-07-02 | 2012-12-04 | C. R. Bard, Inc. | Tip configurations for a multi-lumen catheter |
JP2008517651A (en) * | 2004-10-22 | 2008-05-29 | コーブ・カーディオヴァスキュラー・インコーポレーテッド | Convertible extracorporeal blood perfusion system |
CA2592142A1 (en) * | 2004-12-22 | 2006-06-29 | Emory University | Therapeutic adjuncts to enhance the organ protective effects of postconditioning |
US8465500B2 (en) | 2005-01-21 | 2013-06-18 | Mayo Foundation For Medical Education And Research | Thorascopic heart valve repair method and apparatus |
US8491644B1 (en) | 2005-02-22 | 2013-07-23 | Medivance Incorporated | Portable, refrigerant-based apparatus and method for rapid systemic patient cooling |
US8550973B2 (en) * | 2006-01-09 | 2013-10-08 | Cardiacassist, Inc. | Percutaneous right ventricular assist apparatus and method |
US20080065156A1 (en) | 2006-09-08 | 2008-03-13 | Hauser David L | Expandable clip for tissue repair |
WO2008115106A1 (en) * | 2007-03-19 | 2008-09-25 | Fagerdala Por-Pac Ab | Floating tray |
US8753373B2 (en) * | 2007-05-08 | 2014-06-17 | Edwards Lifesciences Corporation | Suture-fastening clip |
EP2246080B1 (en) | 2007-10-12 | 2016-02-10 | DEKA Products Limited Partnership | An extracorporeal blood flow system |
US8500939B2 (en) | 2007-10-17 | 2013-08-06 | Bard Access Systems, Inc. | Manufacture of split tip catheters |
US9192374B2 (en) | 2007-10-18 | 2015-11-24 | Neochord, Inc. | Minimally invasive repair of a valve leaflet in a beating heart |
US8292841B2 (en) | 2007-10-26 | 2012-10-23 | C. R. Bard, Inc. | Solid-body catheter including lateral distal openings |
US8066660B2 (en) | 2007-10-26 | 2011-11-29 | C. R. Bard, Inc. | Split-tip catheter including lateral distal openings |
US9579485B2 (en) | 2007-11-01 | 2017-02-28 | C. R. Bard, Inc. | Catheter assembly including a multi-lumen configuration |
WO2009059220A1 (en) | 2007-11-01 | 2009-05-07 | C.R. Bard, Inc. | Catheter assembly including triple lumen tip |
US8413872B2 (en) | 2009-10-28 | 2013-04-09 | Covidien Lp | Surgical fastening apparatus |
US8562519B2 (en) * | 2009-12-31 | 2013-10-22 | Cardiacassist, Inc. | Pumping system and method for assisting a patient's heart |
DE102010020838A1 (en) | 2010-05-18 | 2011-11-24 | Fresenius Medical Care Deutschland Gmbh | Valve assembly for use in extracorporeal blood circulation and method |
US8591450B2 (en) | 2010-06-07 | 2013-11-26 | Rex Medical L.P. | Dialysis catheter |
WO2012141757A1 (en) | 2010-12-29 | 2012-10-18 | Neochord, Inc. | Exchangeable system for minimally invasive beating heart repair of heart valve leaflets |
US20130035757A1 (en) | 2011-06-01 | 2013-02-07 | John Zentgraf | Minimally invasive repair of heart valve leaflets |
US9168352B2 (en) | 2011-12-19 | 2015-10-27 | Cardiacassist, Inc. | Dual lumen cannula |
USD748252S1 (en) | 2013-02-08 | 2016-01-26 | C. R. Bard, Inc. | Multi-lumen catheter tip |
WO2016011091A1 (en) | 2014-07-14 | 2016-01-21 | C. R. Bard, Inc. | Apparatuses, systems, and methods for inserting split tip catheters having enhanced stiffening and guiding features |
GB2540566A (en) * | 2015-07-21 | 2017-01-25 | Spectrum Medical Ltd | Control system |
US10765517B2 (en) | 2015-10-01 | 2020-09-08 | Neochord, Inc. | Ringless web for repair of heart valves |
US10213306B2 (en) | 2017-03-31 | 2019-02-26 | Neochord, Inc. | Minimally invasive heart valve repair in a beating heart |
WO2019183626A1 (en) | 2018-03-23 | 2019-09-26 | Neochord, Inc. | Device for suture attachment for minimally invasive heart valve repair |
US11253360B2 (en) | 2018-05-09 | 2022-02-22 | Neochord, Inc. | Low profile tissue anchor for minimally invasive heart valve repair |
US11173030B2 (en) | 2018-05-09 | 2021-11-16 | Neochord, Inc. | Suture length adjustment for minimally invasive heart valve repair |
CN113194854A (en) | 2018-09-07 | 2021-07-30 | 尼奥绰德有限公司 | Suture attachment device for minimally invasive heart valve repair |
US11638805B2 (en) * | 2019-02-27 | 2023-05-02 | Avent, Inc. | Multi-headed catheter for fluid delivery |
WO2020214818A1 (en) | 2019-04-16 | 2020-10-22 | Neochord, Inc. | Transverse helical cardiac anchor for minimally invasive heart valve repair |
IL305233A (en) * | 2021-02-22 | 2023-10-01 | Dinaqor Ag | Loco-regional perfusion of an unarrested beating heart |
Family Cites Families (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1756670A (en) | 1928-08-06 | 1930-04-29 | Lester A Treat | Vulva clamp |
US2406207A (en) * | 1944-10-04 | 1946-08-20 | John P Desmet | Blood treating device |
US3254650A (en) | 1962-03-19 | 1966-06-07 | Michael B Collito | Surgical anastomosis methods and devices |
US3254651A (en) | 1962-09-12 | 1966-06-07 | Babies Hospital | Surgical anastomosis methods and devices |
US3421497A (en) * | 1964-02-26 | 1969-01-14 | United Aircraft Corp | Heart pump system |
US3519187A (en) | 1966-12-06 | 1970-07-07 | Nickolai Nickolajevich Kapitan | Instrument for suturing vessels |
US3570497A (en) | 1969-01-16 | 1971-03-16 | Gerald M Lemole | Suture apparatus and methods |
US3774615A (en) | 1971-02-08 | 1973-11-27 | Ceskoslovenska Akademie Ved | Device for connecting or joining the ends of interrupted tubular organs in surgical operations without stitching |
US3792978A (en) * | 1972-05-30 | 1974-02-19 | Sci Med Life Syst Inc | Envelope assembly for spool type oxygenator |
FR2198759B1 (en) * | 1972-09-12 | 1976-06-04 | Rhone Poulenc Ind | |
US3949734A (en) * | 1974-07-22 | 1976-04-13 | Miles Lowell Edwards | Fluid pump control system |
DE2658478C2 (en) | 1976-12-23 | 1978-11-30 | Aesculap-Werke Ag Vormals Jetter & Scheerer, 7200 Tuttlingen | Vascular clips for surgical use |
CS200909B1 (en) * | 1977-12-23 | 1980-10-31 | Petr Slovak | Haemodlialysation device |
SU1088712A1 (en) | 1979-11-14 | 1984-04-30 | Всесоюзный научно-исследовательский и испытательный институт медицинской техники | Apparatus for circular suture of blood vessels |
US4352358A (en) | 1979-12-28 | 1982-10-05 | Angelchik Jean P | Apparatus for effecting anastomotic procedures |
US4368736A (en) | 1980-11-17 | 1983-01-18 | Kaster Robert L | Anastomotic fitting |
US4366819A (en) | 1980-11-17 | 1983-01-04 | Kaster Robert L | Anastomotic fitting |
US4809695A (en) | 1981-10-21 | 1989-03-07 | Owen M. Gwathmey | Suturing assembly and method |
US4624255A (en) | 1982-02-18 | 1986-11-25 | Schenck Robert R | Apparatus for anastomosing living vessels |
US4474181A (en) | 1982-02-18 | 1984-10-02 | Schenck Robert R | Method and apparatus for anastomosing small blood vessels |
SE431609B (en) | 1982-06-24 | 1984-02-20 | Unilink Ab | SURGICAL INSTRUMENT FOR THE ASTAD COMMAND OF ANASTOMOS AND ITS PARTS |
US4917091A (en) | 1982-06-24 | 1990-04-17 | Unilink Ab | Annular fastening means |
US4540399A (en) * | 1983-02-01 | 1985-09-10 | Ken Litzie | Emergency bypass system |
US4523592A (en) | 1983-04-25 | 1985-06-18 | Rollin K. Daniel P.S.C. | Anastomotic coupling means capable of end-to-end and end-to-side anastomosis |
US4607637A (en) | 1983-07-22 | 1986-08-26 | Anders Berggren | Surgical instrument for performing anastomosis with the aid of ring-like fastening elements and the fastening elements for performing anastomosis |
FR2550583B1 (en) * | 1983-08-08 | 1986-03-28 | Delecroix Michel | DEVICE FOR REGULATING A PUMP |
US4505414A (en) | 1983-10-12 | 1985-03-19 | Filipi Charles J | Expandable anvil surgical stapler |
US5190546A (en) | 1983-10-14 | 1993-03-02 | Raychem Corporation | Medical devices incorporating SIM alloy elements |
US4917087A (en) | 1984-04-10 | 1990-04-17 | Walsh Manufacturing (Mississuaga) Limited | Anastomosis devices, kits and method |
US4657019A (en) | 1984-04-10 | 1987-04-14 | Idea Research Investment Fund, Inc. | Anastomosis devices and kits |
US4671279A (en) | 1984-04-24 | 1987-06-09 | Beta Phase, Inc. | Surgical staple applying method |
US4610656A (en) * | 1984-08-21 | 1986-09-09 | Mehealus Partnership | Fully portable semi-automatic mechanical heart-lung substitution system and method |
US4610658A (en) * | 1985-02-21 | 1986-09-09 | Henry Buchwald | Automated peritoneovenous shunt |
US4639252A (en) * | 1985-04-05 | 1987-01-27 | Research Medical, Inc. | Venous return catheter |
US4593693A (en) | 1985-04-26 | 1986-06-10 | Schenck Robert R | Methods and apparatus for anastomosing living vessels |
US4665908A (en) | 1985-06-11 | 1987-05-19 | Calkin Carston R | Extrication and spinal restraint device |
CN85106639B (en) | 1985-09-03 | 1988-08-03 | 第三军医大学野战外科研究所 | Instrument for blood vessel anastomosis |
FR2587219B1 (en) * | 1985-09-16 | 1987-12-18 | Charvin Guy | CONNECTION DEVICE FOR EXTRA-BODY CIRCULATION CIRCUIT |
US4705508A (en) * | 1985-09-30 | 1987-11-10 | Regents Of The University Of Minnesota | Apparatus and method for rapid infusion of circulatory supportive fluids |
US4666425A (en) * | 1985-12-17 | 1987-05-19 | The Dis Corporation | Device for perfusing an animal head |
US4685906A (en) * | 1986-03-31 | 1987-08-11 | Murphy William F | Eye-drops application device |
US4804365A (en) * | 1987-02-13 | 1989-02-14 | C. R. Bard | Vascular cannulae for transfemoral cardiopulmonary bypass and method of use |
US5119983A (en) | 1987-05-26 | 1992-06-09 | United States Surgical Corporation | Surgical stapler apparatus |
US4907591A (en) | 1988-03-29 | 1990-03-13 | Pfizer Hospital Products Group, Inc. | Surgical instrument for establishing compression anastomosis |
US5069661A (en) * | 1988-05-18 | 1991-12-03 | Brigham And Women's Hospital | Circulatory support system |
US5011469A (en) * | 1988-08-29 | 1991-04-30 | Shiley, Inc. | Peripheral cardiopulmonary bypass and coronary reperfusion system |
US5336233A (en) | 1989-01-26 | 1994-08-09 | Chen Fusen H | Anastomotic device |
US5053047A (en) | 1989-05-16 | 1991-10-01 | Inbae Yoon | Suture devices particularly useful in endoscopic surgery and methods of suturing |
US5324447A (en) | 1989-10-02 | 1994-06-28 | Allergan, Inc. | Method and activator compositions to disinfect lenses |
US5366462A (en) | 1990-08-28 | 1994-11-22 | Robert L. Kaster | Method of side-to-end vascular anastomotic stapling |
US5190528A (en) * | 1990-10-19 | 1993-03-02 | Boston University | Percutaneous transseptal left atrial cannulation system |
US5308320A (en) * | 1990-12-28 | 1994-05-03 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Portable and modular cardiopulmonary bypass apparatus and associated aortic balloon catheter and associated method |
GB9111972D0 (en) | 1991-06-04 | 1991-07-24 | Clinical Product Dev Ltd | Medical/surgical devices |
US6029671A (en) * | 1991-07-16 | 2000-02-29 | Heartport, Inc. | System and methods for performing endovascular procedures |
US5452733A (en) * | 1993-02-22 | 1995-09-26 | Stanford Surgical Technologies, Inc. | Methods for performing thoracoscopic coronary artery bypass |
US5766151A (en) * | 1991-07-16 | 1998-06-16 | Heartport, Inc. | Endovascular system for arresting the heart |
JP2979804B2 (en) * | 1991-12-13 | 1999-11-15 | 株式会社ニッショー | Aortic occlusion balloon catheter |
US5342181A (en) * | 1992-06-15 | 1994-08-30 | Datascope Investment Corp. | Single roller blood pump and pump/oxygenator system using same |
US5522834A (en) | 1992-10-15 | 1996-06-04 | Applied Medical Resources Corporation | Internal mammary artery catheter and method |
US5540653A (en) * | 1992-10-23 | 1996-07-30 | Datascope Investment Corp. | Preassembled bypass circuit |
US5423769A (en) * | 1993-02-09 | 1995-06-13 | Dlp, Inc. | Cardioplegia management system |
US5478354A (en) | 1993-07-14 | 1995-12-26 | United States Surgical Corporation | Wound closing apparatus and method |
US5597377A (en) * | 1994-05-06 | 1997-01-28 | Trustees Of Boston University | Coronary sinus reperfusion catheter |
US6152141A (en) * | 1994-07-28 | 2000-11-28 | Heartport, Inc. | Method for delivery of therapeutic agents to the heart |
US5554162A (en) | 1994-12-02 | 1996-09-10 | Delange; Gregory S. | Method and device for surgically joining luminal structures |
US5620452A (en) | 1994-12-22 | 1997-04-15 | Yoon; Inbae | Surgical clip with ductile tissue penetrating members |
US5695504A (en) | 1995-02-24 | 1997-12-09 | Heartport, Inc. | Devices and methods for performing a vascular anastomosis |
US5702412A (en) | 1995-10-03 | 1997-12-30 | Cedars-Sinai Medical Center | Method and devices for performing vascular anastomosis |
US5810851A (en) | 1996-03-05 | 1998-09-22 | Yoon; Inbae | Suture spring device |
US5746709A (en) * | 1996-04-25 | 1998-05-05 | Medtronic, Inc. | Intravascular pump and bypass assembly and method for using the same |
JP3207440B2 (en) | 1996-04-30 | 2001-09-10 | オチコン アクツイエセルスカプ | Anastomotic device for use when performing end-to-end anastomosis |
US5972024A (en) | 1996-12-24 | 1999-10-26 | Metacardia, Inc. | Suture-staple apparatus and method |
US5957879A (en) * | 1997-01-24 | 1999-09-28 | Heartport, Inc. | Methods and devices for maintaining cardiopulmonary bypass and arresting a patient's heart |
US6090096A (en) * | 1997-04-23 | 2000-07-18 | Heartport, Inc. | Antegrade cardioplegia catheter and method |
US6264645B1 (en) * | 1997-08-14 | 2001-07-24 | Medtronic, Inc. | Method of pressurizing the right ventricle of the heart |
US6315751B1 (en) * | 1997-08-15 | 2001-11-13 | Cleveland Clinic Foundation | Cardiopulmonary bypass system using vacuum assisted venous drainage |
US6100082A (en) * | 1997-09-23 | 2000-08-08 | Hassanein; Waleed H. | Perfusion apparatus and method including chemical compositions for maintaining an organ |
AU5694199A (en) * | 1998-08-27 | 2000-03-21 | A-Med Systems, Inc. | Intravascular cannulation apparatus and methods of use |
-
1997
- 1997-01-24 US US08/789,223 patent/US5957879A/en not_active Expired - Lifetime
-
1999
- 1999-09-23 US US09/401,734 patent/US6443922B1/en not_active Expired - Lifetime
-
2002
- 2002-07-11 US US10/193,627 patent/US6974434B2/en not_active Expired - Fee Related
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7238165B2 (en) | 2002-02-21 | 2007-07-03 | Design Mentor, Inc. | Fluid pump |
US7850593B2 (en) | 2002-02-21 | 2010-12-14 | Design Mentor, Inc. | Fluid pump |
US20060155237A1 (en) * | 2004-11-18 | 2006-07-13 | Venkataramana Vijay | Integrated cardiopulmonary bypass system for open and closed bypass circuits |
US7458952B2 (en) | 2004-11-18 | 2008-12-02 | Venkataramana Vijay | Integrated cardiopulmonary bypass system for open and closed bypass circuits |
WO2012071413A2 (en) * | 2010-11-23 | 2012-05-31 | The Trustees Of Columbia University In The City Of New York | Assembly and method for coronary sinus cannulation |
WO2012071413A3 (en) * | 2010-11-23 | 2014-04-03 | The Trustees Of Columbia University In The City Of New York | Assembly and method for coronary sinus cannulation |
WO2016119771A3 (en) * | 2015-01-26 | 2016-10-20 | Xenios Ag | Assembly comprising a suction line, a pressure line and a pump |
CN108601881A (en) * | 2015-01-26 | 2018-09-28 | 伊克尼奥斯股份有限公司 | With the device for drawing circuit, pressure line and pump |
US10729840B2 (en) | 2015-01-26 | 2020-08-04 | Xenios Ag | Assembly comprising a suction line, a pressure line and a pump |
Also Published As
Publication number | Publication date |
---|---|
US5957879A (en) | 1999-09-28 |
US6443922B1 (en) | 2002-09-03 |
US20020176797A1 (en) | 2002-11-28 |
US6974434B2 (en) | 2005-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6443922B1 (en) | Methods and devices for maintaining cardiopulmonary bypass and arresting a patient's heart | |
EP0912212B1 (en) | Devices for occluding a patient's ascending aorta | |
US6090096A (en) | Antegrade cardioplegia catheter and method | |
CA2288755C (en) | Catheter system | |
US6083198A (en) | Perfusion catheter providing segmented flow regions and methods of use | |
EP1076573B1 (en) | Circulatory support system for isolated segmental perfusion | |
US6682499B2 (en) | Method and apparatus for venous drainage and retrograde coronary perfusion | |
JP3618754B2 (en) | Cardiopulmonary bypass system for performing chest closure intervention | |
US7879003B2 (en) | Multichannel catheter with obturator | |
WO1999004836A9 (en) | Catheter system and method for posterior epicardial revascularization and intracardiac surgery on a beating heart | |
JPH09502889A (en) | Endovascular device for cardiac arrest | |
JPS60210262A (en) | Medical catheter | |
US20030130610A1 (en) | Aortic balloon catheter with improved positioning and balloon stability | |
Lundy et al. | A simple and safe technique of left ventricular venting | |
Wimmer-Greinecker et al. | Perfusion strategies for totally endoscopic cardiac surgery | |
WO2001056643A1 (en) | Aortic balloon catheter with improved positioning and balloon stability |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
AS | Assignment |
Owner name: EDWARDS LIFESCIENCES, LLC, CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:HEARTPORT, INC.;REEL/FRAME:020753/0153 Effective date: 20071219 |
|
FEPP | Fee payment procedure |
Free format text: PAYER NUMBER DE-ASSIGNED (ORIGINAL EVENT CODE: RMPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
FPAY | Fee payment |
Year of fee payment: 8 |
|
AS | Assignment |
Owner name: HEARTPORT, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ROBERTS, CRAIG P.;TOOMASIAN, JOHN M.;FAN, SYLVIA W.;SIGNING DATES FROM 19970121 TO 19970130;REEL/FRAME:024927/0260 |
|
FPAY | Fee payment |
Year of fee payment: 12 |